(Q43191418)
Statements
A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group (English)
M M Moore
M Stockler
R Lim
16 January 2010
1 reference
scientific article published on 16 January 2010